SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069) (TLSA) — Nov 2, 2018

Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)
Date: Nov. 2, 2018 · CIK: 0001723069 · Accession: 0001213900-18-014823

AI Filing Summary & Sentiment

File numbers found in text: 333-226368

Date
Nov. 2, 2018
Author
TIZIANA
Form
CORRESP
Company
Tiziana Life Sciences Ltd (TLSA) (CIK 0001723069)

Letter

Tiziana Life Sciences plc

3rd Floor, 11-12 St James’s Square

London SW1Y 4LB

United Kingdom

November 2, 2018

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Attention: Rolf Sundwall

Mark Brunhofer

Christine Westbrook

Suzanne Hayes

Re: Tiziana Life Sciences plc

Acceleration Request for Registration Statement on Form F-1

File No. 333-226368

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Tiziana Life Sciences plc (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to Monday, November 5, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Cooley (UK) LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Cooley (UK) LLP, by calling Edward Lukins at +44 (0) 20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230.

If you have any questions regarding this request, please contact our counsel, Cooley (UK) LLP, by calling Edward Lukins at +44 (0) 20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230. Thank you for your assistance with this matter.

Sincerely,
TIZIANA
LIFE SCIENCES PLC

Show Raw Text
CORRESP
1
filename1.htm

Tiziana Life Sciences plc

3rd Floor, 11-12 St James’s Square

London SW1Y 4LB

United Kingdom

November
2, 2018

VIA
EDGAR

United
States Securities and Exchange Commission

Division of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

Attention: Rolf
Sundwall

Mark
Brunhofer

Christine Westbrook

Suzanne
Hayes

Re: Tiziana
Life Sciences plc

Acceleration
Request for Registration Statement on Form F-1

File No. 333-226368

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Tiziana Life Sciences plc (the “Company”)
hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”)
be accelerated to Monday, November 5, 2018, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our
outside counsel, Cooley (UK) LLP, request by telephone that such Registration Statement be declared effective at some other time.
In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once
the Registration Statement is effective, please orally confirm the event with our counsel, Cooley (UK) LLP, by calling Edward
Lukins at +44 (0) 20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230.

If
you have any questions regarding this request, please contact our counsel, Cooley (UK) LLP, by calling Edward Lukins at +44 (0)
20 7556 4261 or Edward Dyson at +44(0) 20 7556 4230. Thank you for your assistance with this matter.

    Sincerely,

    TIZIANA
    LIFE SCIENCES PLC

    /s/ Kunwar
    Shailubhai

    Kunwar
    Shailubhai

    Chief
    Executive Officer